Found: 28
Select item for more details and to access through your institution.
Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-671
- By:
- Publication type:
- Article
Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Tc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with Y microspheres.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 12, p. 2328, doi. 10.1007/s00259-010-1566-2
- By:
- Publication type:
- Article
PET with <sup>18</sup>F-labelled choline-based tracers for tumour imaging: a review of the literature.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 11, p. 2188, doi. 10.1007/s00259-010-1496-z
- By:
- Publication type:
- Article
<sup>188</sup>Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 3, p. 344, doi. 10.1007/s00259-005-1954-1
- By:
- Publication type:
- Article
Treatment of hepatocellular carcinoma by means of radiopharmaceuticals.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 8, p. 980, doi. 10.1007/s00259-005-1859-z
- By:
- Publication type:
- Article
Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
- Published in:
- Trials, 2012, v. 13, n. 1, p. 144, doi. 10.1186/1745-6215-13-144
- By:
- Publication type:
- Article
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer.
- Published in:
- Prostate, 2014, v. 74, n. 3, p. 297, doi. 10.1002/pros.22750
- By:
- Publication type:
- Article
Guidelines on nuclear medicine imaging in neuroblastoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 11, p. 2009, doi. 10.1007/s00259-018-4070-8
- By:
- Publication type:
- Article
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 2, p. 292, doi. 10.1007/s00259-017-3829-7
- By:
- Publication type:
- Article
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 2, p. 222, doi. 10.1007/s00259-014-2909-1
- By:
- Publication type:
- Article
Intra-arterial treatment with Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 12, p. 2117, doi. 10.1007/s00259-011-1881-2
- By:
- Publication type:
- Article
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 7, p. 1393, doi. 10.1007/s00259-011-1812-2
- By:
- Publication type:
- Article
Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients.
- Published in:
- Diagnostics (2075-4418), 2017, v. 7, n. 4, p. 56, doi. 10.3390/diagnostics7040056
- By:
- Publication type:
- Article
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy.
- Published in:
- BJU International, 2017, v. 120, n. 6, p. 815, doi. 10.1111/bju.13938
- By:
- Publication type:
- Article
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1748-717X-9-135
- By:
- Publication type:
- Article
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (<sup>18</sup> F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Salvage Pelvic Lymph Node Dissection in Recurrent Prostate Cancer: Surgical and Early Oncological Outcome.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/198543
- By:
- Publication type:
- Article
Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-016-0245-0
- By:
- Publication type:
- Article
Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2006, v. 84, n. 10, p. 1021, doi. 10.1139/Y06-055
- By:
- Publication type:
- Article
Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 3, p. 502, doi. 10.2967/jnumed.117.195883
- By:
- Publication type:
- Article
Pretreatment Dosimetry in HCC Radioembolization with <sup>90</sup>Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of <sup>99m</sup>Tc-MAA Uptake of Colorectal Metastases Treated with Resin Microspheres.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1215, doi. 10.2967/jnumed.113.129361
- By:
- Publication type:
- Article
Advantage of <sup>188</sup>Re-Radiopharmaceuticals in Hepatocellular Cancer and Liver Metastases.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 8, p. 1407
- By:
- Publication type:
- Article
<sup>188</sup>Re-HDD/Lipiodol for Treatment of Hepatocellular Carcinoma: A Feasibility Study in Patients with Advanced Cirrhosis.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 8, p. 1326
- By:
- Publication type:
- Article
<sup>188</sup>Re-HDD/Lipiodol Therapy for Hepatocellular Carcinoma: A Phase I Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 1, p. 60
- By:
- Publication type:
- Article
Bone Marrow Dosimetry and Safety of High <sup>131</sup>I Activities Given After Recombinant Human Thyroid-Stimulating Hormone to Treat Metastatic Differentiated Thyroid Cancer.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 9, p. 1549
- By:
- Publication type:
- Article
Biologic Dosimetry of <sup>188</sup>Re-HDD/Lipiodol Versus <sup>131</sup>I-Lipiodol Therapy in Patients with Hepatocellular Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 4, p. 612
- By:
- Publication type:
- Article